The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The impact of drug-induced QT interval prolongation on drug discovery and development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
A structural basis for drug-induced long QT syndrome
Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210244497 · Cited by 944
Center for Drug Evaluation and Research
National Cancer Institute (2020) · Definitions · doi:10.32388/doq9wu · Cited by 674
Torsades de Pointes Occurring in Association With Terfenadine Use
Monahan, B. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450210088038 · Cited by 667
Mechanism of the Cardiotoxic Actions of Terfenadine
Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646
Cellular mechanisms underlying the long QT syndrome
Antzelevitch, C., & Shimizu, W. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200201000-00007 · Cited by 313
Roden, D. M., Balser, J. R., George Jr, A. L., & Anderson, M. E. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.083101.145105 · Cited by 305
HERG, a Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine
Roy, M.-L., Dumaine, R., & Brown, A. M. (1996) · Circulation · doi:10.1161/01.cir.94.4.817 · Cited by 303
Bednar, M. M., Harrigan, E. P., Anziano, R. J., Camm, A. J., & Ruskin, J. N. (2001) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2001.21469 · Cited by 265
Torsade de pointes due to quinidine: Observations in 31 patients
Bauman, J. L., Bauernfeind, R. A., Hoff, J. V., Strasberg, B., Swiryn, S., & Rosen, K. M. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90081-4 · Cited by 208
Cell-based assays and instrumentation for screening ion-channel targets
González, J. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01383-5 · Cited by 178
Cardiotoxic effect with convulsions in terfenadine overdose.
Davies, A. J., Harindra, V., McEwan, A., & Ghose, R. R. (1989) · BMJ · doi:10.1136/bmj.298.6669.325 · Cited by 164
Gintant, G. A., Limberis, J. T., McDermott, J. S., Wegner, C. D., & Cox, B. F. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200105000-00012 · Cited by 158
Cavero, I., Mestre, M., Guillon, J.-M., & Crumb, W. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.947 · Cited by 139
High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage Clamp
Kiss, L., Bennett, P. B., Uebele, V. N., Koblan, K. S., Kane, S. A., Neagle, B., & Schroeder, K. S. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803321537845 · Cited by 134
Risks of non-sedating antihistamines
Lindquist, M., & Edwards, I. R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)26018-6 · Cited by 122
Witchel, H. J., Pabbathi, V. K., Hofmann, G., Paul, A. A., & Hancox, J. C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03320-8 · Cited by 117
Fluoxetine-induced bradycardia and syncope in two patients.
Ellison, J. M., Milofsky, J. E., & Ely, E. (1990) · PubMed · Cited by 80
Shah, R. R. (2002) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2002.00083.x · Cited by 76
Patmore, L., Stuart, F., Mair, D., & Templeton, A. G. B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00694-4 · Cited by 68
A plethora of mechanisms in the HERG-related long QT syndrome Genetics meets electrophysiology
Roden, D. M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00224-2 · Cited by 58
Chadwick, C. C., Ezrin, A. M., O'Connor, B., Volberg, W. A., Smith, D. I., Wedge, K. J., Hill, R., Briggs, G. M., Pagani, E. D., & Silver, P. J. (1993) · Circulation Research · doi:10.1161/01.res.72.3.707 · Cited by 54
Fluoxetine (Prozac) as a Cause of QT Prolongation
Varriale, P. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.4.612 · Cited by 49
[3H]Dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?
Finlayson, K., Pennington, A. J., & Kelly, J. S. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00731-2 · Cited by 42
Antihistamines--is there anything safe to prescribe?
Kemp, J. (1992) · PubMed · Cited by 35
Zipes, D. P. (1993) · Cardiology in Review · doi:10.1097/00045415-199301010-00001 · Cited by 15
Cited by
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100008c · Cited by 1,063
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049
Liang, P., Lan, F., Lee, A. S., Gong, T., Sanchez-Freire, V., Wang, Y., Diecke, S., Sallam, K., Knowles, J. W., Wang, P. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001883 · Cited by 537
Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine Basicities
Morgenthaler, M., Schweizer, E., Hoffmann‐Röder, A., Benini, F., Martin, R. E., Jaeschke, G., Wagner, B., Fischer, H., Bendels, S., Zimmerli, D., et al. (2007) · ChemMedChem · doi:10.1002/cmdc.200700059 · Cited by 518
Metadata
- Authors
- Fermini, B., & Fossa, A. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-06
- Volume
- 2
- Issue
- 6
- Pages
- 439-447
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2052017927
- Cited by
- 492
- References
- 27
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.